Overall Technical outlook

Price Summary

Suven Pharmaceuticals Limited's stock slumped -5.36% today, reflecting an mediocrending market day.
On 2025-04-25, Suven Pharmaceuticals Limited's stock began at 1208.0, climbed to 1219.5, dropped to 1137.8, and had -5.36% to end at 1143.2, with a volume of 182742 shares.
During the past 52 weeks, the highest stock price was 1334.2, and the lowest was 610.5.
Analysts expect the price of SUVENPHAR to vary between 1290.0 and 1500.0, with an average expected price near 1396.6666.

Technicals

Support and Resistance: The current price for SUVENPHAR is 1143.2, supported at 1130.1 with resistance at 1204.55. This indicates a trading range where 1130.1 might prevent further declines, while 1204.55 could hinder additional gains.
SUVENPHAR supportResistance 2677eb
Support/Resistance for SUVENPHAR


Aroon: The AROON is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
SUVENPHAR aroon 2677eb
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
SUVENPHAR bbands 2677eb
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, setting a critical support level that may help sustain the market's upward trend. This persistent bullish outlook suggests that the market is likely to continue climbing, with the support level offering a foundation for further growth.
SUVENPHAR psar 2677eb
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
SUVENPHAR stoch 2677eb
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
SUVENPHAR trippleSMA 2677eb
Tripple SMA chart for Suven Pharmaceuticals Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.